EMEA-000470-PIP01-08-M10

Key facts

Invented name
Januvia
Active substance
sitagliptin
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0033/2018
PIP number
EMEA-000470-PIP01-08-M10
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of type II diabetes mellitus
Route(s) of administration
Oral use
Contact for public enquiries
Merck Sharp and Dohme (Europe), Inc.
Tel. +44 (0)1992 452396
E-mail: paul.robinson@merck.com
 
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating